Merck Sharp & Dohme B.V. (Batch release, testing at release)

The drug is intended for adults with type 2 diabetes to improve blood sugar control. It can be used either as monotherapy or in combination with other medications (e.g., metformin, sulfonylurea, or insulin).

Dosage form: tablets, film-coated

ATC: A10BH01